• If you are wondering whether Edgewell Personal Care at around US$22.79 is a bargain or a value trap, it helps to break the story into recent returns, business context, and what the numbers actually say about price versus value.
• The stock has had a mixed run, with a 1.3% decline over the last 7 days, an 8.4% gain over 30 days, a 35.2% gain year to date, a 24.1% decline over the past year, a 45.3% decline over 3 years, and a 37.1% decline over 5 years.
• Recent attention on Edgewell Personal Care has centered on its position in the Personal Products space and how investors are weighing its brand portfolio and competitive standing against its share price. This context helps explain why some are reassessing whether the recent rebound is a reset in expectations or simply a short term swing.
• The company currently has a valuation score of 5/6. The next sections will break down how different valuation approaches arrive at that view, before finishing with a broader framework that can help you assess whether the current price really fits your own thesis.

Approach 1: Edgewell Personal Care Discounted Cash Flow (DCF) Analysis

A DCF model takes estimates of the cash a business could generate in the future, then discounts those cash flows back to today to arrive at an implied value per share.

For Edgewell Personal Care, the latest trailing twelve month Free Cash Flow (FCF) is about $46.9 million. Using a 2 Stage Free Cash Flow to Equity model, analyst inputs and Simply Wall St extrapolations project FCF rising to $108.6 million in 2026 and $137.3 million in 2027, with further estimated cash flows out to 2035. Each of these future cash flows is discounted back to today and summed.

On this basis, the model arrives at an estimated intrinsic value of about $46.69 per share, compared with the recent share price around $22.79. That implies an intrinsic discount of roughly 51.2%, which indicates that the shares screen as undervalued on this DCF view alone.

Result: UNDERVALUED

Our Discounted Cash Flow (DCF) analysis suggests Edgewell Personal Care is undervalued by 51.2%. Track this in your watchlist or portfolio, or discover 53 more high quality undervalued stocks.

Approach 2: Edgewell Personal Care Price vs Sales

For a consumer products business like Edgewell Personal Care, the P/S ratio is a useful yardstick because it compares what you are paying to the revenue the company generates, and it can be especially helpful when earnings are influenced by accounting items or are relatively small.

In broad terms, higher growth expectations and lower perceived risk can support a higher "normal" or "fair" P/S multiple, while slower growth or higher risk usually points to a lower multiple being reasonable.

Edgewell Personal Care currently trades on a P/S of 0.48x, compared with the Personal Products industry average of about 1.00x and a peer average of 1.25x. Simply Wall St’s Fair Ratio for the company is 0.60x, which reflects what its P/S might be expected to be given factors such as earnings growth, profit margins, industry, market cap and company specific risks.

This Fair Ratio is more tailored than a simple comparison with peers or the industry, because it adjusts for the company’s own growth profile and risk characteristics rather than assuming all companies deserve the same multiple. On this basis, Edgewell Personal Care’s actual P/S of 0.48x sits below the Fair Ratio of 0.60x, which points to the shares screening as undervalued on the P/S approach.

Result: UNDERVALUED

P/S ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 18 top founder-led companies.

Upgrade Your Decision Making: Choose your Edgewell Personal Care Narrative

Earlier it was mentioned that there is an even better way to understand valuation. Narratives are introduced here as simple stories you create about Edgewell Personal Care that link your view of its brands, competition and risks to a financial forecast and a fair value. Using the Community page on Simply Wall St, where millions of investors share views, you can, for example, build a more optimistic Edgewell story closer to the US$32.0 fair value or a more cautious one nearer US$21.0. You can then compare your chosen Fair Value to the current price to help decide whether to buy, hold, or sell, while the platform keeps that Narrative updated automatically when fresh news or earnings are added.

For Edgewell Personal Care, here are previews of two leading Edgewell Personal Care Narratives:

Fair value in this narrative: US$24.17 per share.

Implied discount to this fair value versus the recent US$22.79 price: about 5.7% undervalued.

Analyst revenue assumption used in this narrative: 4.11% annual decline.

• Brands, e-commerce and targeted marketing are used to support margins and keep the core portfolio competitive across international and domestic markets.
• Cost efficiency programs and business transformation efforts are expected to support earnings while funding ongoing brand investment.
• Analysts in this camp see the current price as close to their US$24.17 fair value. They therefore frame the stock as roughly in line with their expectations based on the 2029 earnings and P/E assumptions.

Fair value in this narrative: US$21.00 per share.

Implied premium to this fair value versus the recent US$22.79 price: about 8.5% overvalued.

Analyst revenue assumption used in this narrative: 3.98% annual decline.

• More cautious analysts focus on pressure from changing consumer tastes, private labels and higher costs, which they see as a drag on margins and earnings quality.
• This view accepts that earnings could grow, but only on the back of higher required returns and a lower future P/E multiple than the sector.
• On their US$21.00 fair value, the current price sits above what they are willing to pay. As a result, they regard expectations as demanding relative to their assumptions on growth, profitability and risk.

If you want to see how other investors and analysts connect these moving parts into full stories and valuation ranges, it is worth reading through the different community views for Edgewell Personal Care and seeing which one aligns most closely with your own assumptions.

To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for Edgewell Personal Care on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.

Do you think there's more to the story for Edgewell Personal Care? Head over to our Community to see what others are saying!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.